MetLife Investment Management’s AngioDynamics ANGO Stock Holding History

MetLife Investment Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$240K	Sell	21,076 -533	-2%	-$5.78K	﹤0.01%	2140
2025 Q4	$277K	Hold	21,609	–	–	﹤0.01%	2110
2025 Q3	$241K	Hold	21,609	–	–	﹤0.01%	2212
2025 Q2	$214K	Hold	21,609	–	–	﹤0.01%	2151
2025 Q1	$203K	Sell	21,609 -531	-2%	-$5.58K	﹤0.01%	2194
2024 Q4	$203K	Buy	22,140 +477	+2%	+$3.51K	﹤0.01%	2295
2024 Q3	$169K	Hold	21,663	–	–	﹤0.01%	2370
2024 Q2	$131K	Buy	21,663 +9,597	+80%	+$59.2K	﹤0.01%	2471
2024 Q1	$70.8K	Sell	12,066 -7,585	-39%	-$45.1K	﹤0.01%	2664
2023 Q4	$154K	Hold	19,651	–	–	﹤0.01%	2381
2023 Q3	$144K	Hold	19,651	–	–	﹤0.01%	2389
2023 Q2	$205K	Hold	19,651	–	–	﹤0.01%	2264
2023 Q1	$203K	Hold	19,651	–	–	﹤0.01%	2213
2022 Q4	$271K	Hold	19,651	–	–	﹤0.01%	2055
2022 Q3	$402K	Hold	19,651	–	–	﹤0.01%	1797
2022 Q2	$380K	Hold	19,651	–	–	﹤0.01%	1853
2022 Q1	$423K	Buy	19,651 +7,490	+62%	+$170K	﹤0.01%	1873
2021 Q4	$335K	Hold	12,161	–	–	﹤0.01%	1736
2021 Q3	$315K	Hold	12,161	–	–	﹤0.01%	1796
2021 Q2	$330K	Hold	12,161	–	–	﹤0.01%	1829
2021 Q1	$285K	Sell	12,161 -5,691	-32%	-$115K	﹤0.01%	1846
2020 Q4	$274K	Hold	17,852	–	–	﹤0.01%	1815
2020 Q3	$215K	Hold	17,852	–	–	﹤0.01%	1818
2020 Q2	$182K	Hold	17,852	–	–	﹤0.01%	1966
2020 Q1	$186K	Hold	17,852	–	–	﹤0.01%	1743
2019 Q4	$286K	Hold	17,852	–	–	﹤0.01%	1784
2019 Q3	$329K	Hold	17,852	–	–	﹤0.01%	1655
2019 Q2	$352K	Hold	17,852	–	–	﹤0.01%	1700
2019 Q1	$408K	Hold	17,852	–	–	﹤0.01%	1581
2018 Q4	$359K	Hold	17,852	–	–	﹤0.01%	1562
2018 Q3	$388K	Hold	17,852	–	–	﹤0.01%	1696
2018 Q2	$397K	Hold	17,852	–	–	﹤0.01%	1543
2018 Q1	$308K	Hold	17,852	–	–	﹤0.01%	1659
2017 Q4	$297K	Buy	+17,852	New	+$305K	﹤0.01%	1714

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

MetLife Investment Management's ANGO Position: Q1 2026 in Review

MetLife Investment Management reduced its AngioDynamics (ANGO) stake by 2.5% in Q1 2026, selling an estimated $5.78K and leaving 21,076 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #2140.

MetLife Investment Management first reported a position in ANGO in Q4 2017 and has held it in 34 quarters since. The position peaked at $423K in Q1 2022. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

MetLife Investment Management held 21,076 shares of AngioDynamics worth $240K as of Q1 2026.
MetLife Investment Management sold 533 AngioDynamics shares in Q1 2026, an estimated $5.78K.
AngioDynamics made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2140 holding.
MetLife Investment Management first reported a position in AngioDynamics in Q4 2017 and has held it in 34 quarters since.
MetLife Investment Management's AngioDynamics position peaked at $423K in Q1 2022.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.